Sona Asset Management »

Neurocrine Biosciences Inc Note 2.250 5/1 shares owned by Sona Asset Management

Quarter-by-quarter ownership of Neurocrine Biosciences Inc Note 2.250 5/1 shares owned by Sona Asset Management from 13F filings

Historical chart of Sona Asset Management investment in Neurocrine Biosciences Inc Note 2.250 5/1

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences Inc Note 2.250 5/1 held by Sona Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences Inc Note 2.250 5/1 by Sona Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $26B 18M 1503.88
2023-06-30 $19B 14M 1285.26
2023-03-31 $13B 9.4M 1335.47
2022-12-31 $149k 9.4M 0.02
2022-09-30 $107k 7.5M 0.01
2022-06-30 $50k 3.8M 0.01

More positions owned by Sona Asset Management

Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Apollo Global Mgmt Ser A Mand Cnv (APO.PA)
Insight Enterprises Note 0.750% 2/1
Ncl Corp Note 2.500% 2/1
Rapid7 Note 0.250% 3/1
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Greenfire Res Com Shs (GFR)
Neurocrine Biosciences Note 2.250% 5/1
Dropbox Note3/0
Biomarin Pharmaceutical Note 0.599% 8/0
Dropbox Note3/0
Sea Note 2.375%12/0
Mongodb Note 0.250% 1/1
Sea Note 0.250% 9/1
American Airlines Group Note 6.500% 7/0

View all positions for Sona Asset Management

Top funds holding Neurocrine Biosciences Inc Note 2.250 5/1

Franklin Resources
Tenor Capital Management
D. E. Shaw & Co
CSS
Lord, Abbett & Co
SSI Investment Management
Bnp Paribas Investment Partners
Two Sigma Investments
Agf Management
Citigroup
Sunrise Partners Limited Partnership
Barclays
Jane Street
Fox Hill Wealth Management
Central Pacific Bank - Trust Division

View all funds holding Neurocrine Biosciences Inc Note 2.250 5/1